Screening for prostate cancer: time to put all the data on the table

    loading  Checking for direct PDF access through Ovid

Abstract

Ian Haines and colleagues

call for access to all the publicly funded clinical trial data from two major trials to settle the controversies around screening for prostate cancer with prostate specific antigen

Related Topics

    loading  Loading Related Articles